Ochratoxin A (OTA) is a mycotoxin occurring naturally in a wide range of food commodities. In animals, it has been shown to cause a variety of adverse effects, nephrocarcinogenicity being the most prominent. Because of its high toxic potency and the continuous exposure of the human population, OTA has raised public health concerns. There is significant debate on how to use the rat carcinogenicity data to assess the potential risk to humans. In this context, the question of the mechanism of action of OTA appears of key importance and was studied through the application of a toxicogenomics approach. Male Fischer rats were fed OTA for up to 2 years. Renal tumors were discovered during the last 6 months of the study. The total tumor incidence reached 25% at the end of the study. Gene expression profile was analyzed in groups of animals taken in intervals from 7 days to 12 months. Tissue-specific responses were observed in kidney versus liver. For selected genes, microarray data were confirmed at both mRNA and protein levels. In kidney, several genes known as markers of kidney injury and cell regeneration were significantly modulated by OTA. The expression of genes known to be involved in DNA synthesis and repair, or genes induced as a result of DNA damage, was only marginally modulated. Very little or no effect was found amongst genes associated with apoptosis. Alterations of gene expression indicating effects on calcium homeostasis and a disruption of pathways regulated by the transcription factors hepatocyte nuclear factor 4 alpha (HNF4a) and nuclear factor-erythroid 2-related factor 2 (Nrf2) were observed in the kidney but not in the liver. Previous data have suggested that a reduction in HNF4a may be associated with nephrocarcinogenicity. Many Nrf2-regulated genes are involved in chemical detoxication and antioxidant defense. The depletion of these genes is likely to impair the defense potential of the cells, resulting in chronic elevation of oxidative stress in the kidney. The inhibition of defense mechanism appears as a highly plausible new mechanism, which could contribute to OTA carcinogenicity.
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Ochratoxin A (OTA) is a naturally occurring mycotoxin produced by several species of Aspergillus and Penicillium. As a consequence of its widespread occurrence in a variety of food commodities such as cereals, green coffee, cocoa, dried fruits, and meat products (WHO, 2001) , the human population is continuously exposed to OTA, although usually only in trace amounts.
OTA causes a range of adverse effects in monogastric animals, with renal toxicity being the most prominent (NTP, 1989; O'Brien and Dietrich, 2005; WHO, 2001) . Other OTAmediated toxic effects observed in vitro or in vivo include inhibition of protein synthesis (Dirheimer and Creppy, 1991) , impairment of energetic metabolism WHO, 2001) , induction of oxidative stress (Gautier et al., 2001a; Kamp et al., 2005; Petrik et al., 2003; WHO, 2001) , and apoptosis O'Brien and Dietrich, 2005; Petrik et al., 2003; Sauvant et al., 2005) .
In a 2-year carcinogenicity study, OTA administration by oral gavage caused dose-dependent incidence of renal tumors in male rats, while females were much less susceptible (NTP, 1989) . Similar effects were observed in mice, although at much higher doses (Bendele et al., 1985) . OTA has been suspected to be an etiological agent in the human disease Balkan endemic nephropathy (BEN) and in its association with an increased incidence of urinary tract tumors (Petkova-Bocharova et al., 1988; Plestina et al., 1990) . However, causal involvement of the toxin in these two diseases lacks robust etiological evidence, and the actual health significance of current natural OTA exposure in the human is still unclear.
At present, there is still insufficient mechanistic understanding of OTA toxicity, particularly in respect to the occurrence of renal carcinomas. OTA has, for instance, been shown to alter several cell-signaling pathways known to be involved in carcinogenesis. They include modulation of the calcium-dependent signaling and the mobilization of two mitogen-activated protein kinases (MAPK), the extracellular signal-regulated kinase (ERK1/2) and the c-jun amino terminal kinase (JNK1/2) Sauvant et al., 2005) . 1 To whom correspondence should be addressed at Nestle Research Center, P.O. Box 44, Vers-chez-les Blanc, CH-1000 Lausanne 26, Switzerland. Fax: þþ41 21 785 85 53. E-mail: maricel.marin-kuan@rdls.nestle.com.
Since the carcinogenic mechanism remains obscure, there is still significant debate about the best model for human risk assessment. Knowledge of the extent of a toxicant's genotoxicity is vital in evaluating its potency as a carcinogen. At present, the genotoxic status of OTA is still unclear (Manderville, 2005; Turesky, 2005) , mainly due to contradictory experimental evidence. (1) Applying 32 P-postlabelling, some authors have found low levels of DNA lesions in organs of animals treated with OTA Faucet et al., 2004; Pfohl-Leszkowicz et al., 1993) . These lesions have been interpreted as OTA-specific covalent DNA adducts, suggesting that OTA is a genotoxin sensu stricto. Such a compound would require dose-response modeling for quantitative risk assessment. It has, however, also been suggested that OTA-mediated DNA lesions detected by 32 Ppostlabelling may have arisen through indirect mechanisms rather than direct DNA-binding (Gautier et al., 2001b) . (2) In studies that used radiolabeled OTA, DNA-binding could not be detected (Gautier et al., 2001b; Gross-Steinmeyer et al., 2002; Mally et al., 2004) , indicating that the compound may not be directly genotoxic. If this is the case, an alternative safetybased approach would need to take into account uncertainty factors in order to evaluate the human health risk of OTA exposure.
The aim of the present study was to exploit the power of toxicogenomics to seek evidence for potential involvement of epigenetic mechanisms in OTA carcinogenesis under exposure conditions producing a significant incidence of renal tumors without overt toxicity. Gene expression profiles were analyzed in kidney and liver of male Fischer (F-344) rats, given dietary OTA over various periods ranging from 7 days to 12 months. This duration spans the first half of the standard 2-year protocol for studying lifetime responses to carcinogens.
MATERIALS AND METHODS
Ochratoxins. Standardized OTA production was performed by growing A. ochraceus isolate D2306 (Harris and Mantle, 2001 ) in shaken solid substrate fermentations at 28°C for 2 weeks to yield a product containing 5-6 mg OTA/g. More specifically, 40 g of sterilized shredded wheat (Cereal Partners UK, Welwyn, UK) in 500 ml Erlenmeyer flasks was inoculated with a concentrated spore suspension in water (16 ml), and the flasks were shaken at 200 rpm and 10 cm eccentric throw. An aliquot of each fermentation was assayed for OTAconcentration by HPLC with diode array detection (Harris and Mantle, 2001 ). Batches of fermentation product contained ochratoxin B (OTB) equivalent to 5-10% of the amount of OTA. No other mycotoxins (e.g., penicillic acid, citrinin) were biosynthesized in this fermentation. Each week, a weighed amount of standardized fermentation product was homogenized into powdered standard commercial rat feed (Special Diets Services, UK) to a final concentration appropriate for the required OTA-intake per animal. Each animal was given 20 g of contaminated feed daily, which was always fully consumed.
Animal treatment. Male Fischer 344 (F-344) rats (B. & K. Universal Ltd., Hull, UK) in groups of five were administered OTA in diet given daily over 2 years. As from their initial weight of~175 g, daily dietary intake was 300 lg OTA/kg bw, but was held at 100 lg/rat after animals reached 333 g. Over the period of the study, animals were housed in cages on absorbent paper under tightly controlled conditions (21 ± 1°C, 55 ± 10% relative humidity, airexchange, 12-h light-dark cycle). Animal growth and welfare were monitored by regular weighing and daily surveillance. For the gene expression study, five time points were selected to represent early (7 and 21 days) and later (4, 7, and 12 months) responses. At each time point, four control and treated animals were randomly chosen for tissue harvest. Kidneys and liver from these rats were immediately snap-frozen in liquid nitrogen. All handling and procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986.
RNA isolation.
Homogenates from liver and kidney tissue samples were prepared with the FastPrep system (Q.BIOgene, Germany). Total RNA was isolated using the Clontech Atlas Pure Total RNA Labeling System (BD Biosciences, Switzerland) following the manufacturer's protocol. Total RNAs were treated with DNase I to remove genomic DNA contamination. RNA concentration was measured with the RiboGreen RNA quantification Kit (Molecular Probes, Eugene, OR) according to the manufacturer's instruction. Assessment of RNA quality and measurement of the 28S to 18S ratio were performed by dynamic gel electrophoresis using the Agilent Bioanalyser (Agilent Biotechnologies, Germany).
cRNA preparation. Five lg of total RNA from kidney and liver samples of treated and control rats was used for the synthesis of double-stranded cDNA (Superscript Choice System; Invitrogen Life Technologies, Carlsbad, CA) in the presence of a T7-(dT) DNA oligonucleotide primer. After synthesis, cDNA was purified by phenol/chloroform/isoamyl alcohol extraction and subsequent ethanol precipitation. The purified cDNA was transcribed in vitro using a MEGAscript kit (Ambion Diagnostics, Austin, TX) in the presence of biotinylated ribonucleotides to form biotin-labeled cRNA (ENZO Life Sciences, Farmingdale, NY). Labeled cRNA was purified using a nucleospin matrix (Macherey-Nagel, Germany), quantified by RiboGreen, and its quality was assessed with Agilent Bioanalyzer before subsequent fragmentation.
Hybridisation and labeling. Twenty lg of each fragmented cRNA was hybridized to a GeneChip cartridge, rotated at 60 rpm for 16 h at 40°C. Sample was analyzed independently using the Affymetrix platform RG-U34A expression probe arrays (Affymetrix Inc., Santa Clara, CA) containing 8,799 probe sets. For each time point, at least three independent controls and treated animals were analyzed individually on a GeneChip cartridge. Quality control steps were performed during the microarray procedure and were collected according to the laboratory information management system (L.I.M.S). After hybridization, GeneChips were washed 10 times in 63 SSPE-T at 25°C, followed by four washes in 0.53 SSPE-T at 50°C. GeneChips were stained with 10 lg/ml streptavidin-P-phycoerythrin, SAPE (Molecular Probes Inc., Eugene, OR), in a GeneChip Fluidics Workstation 400 (Affymetrix Inc., Santa Clara, CA). The signal was amplified using biotinylated goat antistreptavidin antibody (Vector Laboratories, Burlingame, CA), followed from a second staining with SAPE. The array was washed and scanned at 560 nm using a confocal laser scanner (GeneArray Scanner 2500, Hewlett Packard).
Data analysis and clustering algorithms. Signals from scanned images were quantified using the Affymetrix Gene Expression Analysis software (MAS 5.0). Normalization of gene expression data was performed. Differences in gene expression occurring in treated rats compared to controls were calculated by applying analysis of variance (ANOVA). This analysis was performed on log-transformed signal values for each gene individually (ByGene test). Three factors were used for ANOVA: treatment, time, and the interaction between treatment and time. ANOVA between the treatments was performed applying the Global Error Assessment method (GEA) as previously described Mutch et al., 2004) . This approach increases the statistical power of the data. Complete data sets generated in this study are available at the NCBI Gene Expression Omnibus (http:// www.ncbi.nlm.nih.gov/geo/), access number GSE2852.
Gene clustering dendrograms were obtained with the software Spotfire (Spotfire Inc.) following the UPGMA clustering and Tanimoto similarity measure (Matter, 1997) . Only genes with a significant p 0.001 in at least two time points were included in dendrograms of differential expression of genes in OCHRATOXIN A CARCINOGENICITY 121 kidney and liver. The vertical axis of each dendrogram shows individually selected probes, whereas the horizontal axis represents the clustering level at the time points studied (7 days, 21 days, 4 months, 7 months, and 12 months).
Single value decomposition. The variability of gene modulation induced by OTA during the time was also investigated by a matrix factorization technique equivalent to Principal Component Analysis (PCA), the singular value decomposition (SVD) method (Alter et al., 2003) . SVD method provides a low-dimensional projection of the original dataset by its decomposition in three quantities-the matrices containing the left-and right-singular vectors of the original data matrix, and the diagonal matrix containing the singular values. Clusters formed by the SVD method can be interpreted as the relative frequencies with which a given gene is modulated at every one of the original single time points which, when combined, form the temporal modes of gene modulation. Average from each SVD-generated cluster was performed in order to evaluate the profile of the gene expression during the time.
Real-time polymerase chain reaction (PCR). Several key genes, each of which represents a category of genes found to be modulated by OTA, were selected to validate the microarray data. RNA preparation, quantification, and quality control were conducted as described above. RNA was converted to cDNA using the two-step TaqMan Gold RT-PCR system (Applied Biosystem, Foster City, CA) containing the TaqMan Reverse Transcription Reagents and the TaqMan PCR Core kit for relative quantification experiments. Reverse transcription was performed in triplicate, according to the manufacturer's instructions (Applied Biosystems, Foster City, CA), using the random hexamers primer and 5 lg of pooled RNA samples. cDNA synthesis was performed in a Thermal Cycler Ò 9600 (Applied Biosystems) under the following conditions: 10 min at 25°C, 30 min at 48°C, and a final inactivation step of 5 min at 95°C. Samples were amplified in a MicroAmp 96-well reaction plate with the ABI Prism Ò 7000 Sequence Detection System using 1 ll of cDNA template and the TaqMan PCR kit (Applied Biosystems). The thermocycler conditions included two incubations of 2 min at 50°C and 10 min at 95°C, followed by 40 cycles, each consisting of a denaturing step for 15 sec at 95°C and a second annealing and extension step for 1 min at 60°C. Quantification of amplified PCR products was performed using ABI Prism Ò 7000 Sequence Detection System software Version 1.1, normalized to the rat 18S gene as internal control. All rat PCR probes and primers used in this study were obtained from the Assays on Demand (AoD) Service of Applied Biosystems.
Protein expression analysis by Western blot. Correlation between mRNA and protein expression was confirmed by Western blot. Briefly, 50 mg of liver and kidney tissue samples were directly homogenized using RIPA (150 mM PBS containing 1% (vol/vol) Igepal CA630, 0.5% (wt/vol) sodium deoxycholate, 0.1% (wt/vol) SDS, and 5 lg/ll protease inhibitor mixture), pH 7.4 (SantaCruz Biotechnology, Santa Cruz, CA) following the manufacturer's instructions. Protein concentration was determined with a BioRad Protein assay kit (Bio-Rad, Richmond, CA). Using the MiniCell XCellSureLock system (Invitrogene), 15 lg of protein was loaded in the NuPAGE Ò Bis-Tris Pre-Cast Gel 4-12% System (Invitrogene Ltd, Paisley, UK). Protein was transferred to a nitrocellulose transfer membrane (Invitrogene) for 1 h at 30 V. Transferred membranes were probed with antibodies specific for the proteins Gstp, Gclc (kindly offered by Dr. Leslie McLellan, Dundee University, Scotland, UK), Oatp1 (kindly offered by Prof. B. Hagenbuch, University of Kansas Medical Center, Kansas City, KS), HNF4a (Abcam, Cambridge, UK), Oct2 and Oat-k1 (Alpha Diagnostic, San Antonio, TX). Each blot was subsequently probed with horseradish peroxidase linked to the specific secondary antibody. Chemiluminescence of the immunoblots was detected using ECL solution (Pierce, Rockford, IL). Membranes were wrapped in polythene film and exposed to Kodak films.
RESULTS
OTA treatment was generally well tolerated throughout the 2-year carcinogenicity study from which the tissue samples for the gene expression study originated. The body weight of treated animals did not differ significantly from that of control animals. All tumors that were found before the 2-year end point of the carcinogenicity study were from animals that had been euthanized because of loss of condition. The first renal tumor was found 75 weeks after OTA treatment commenced (Fig. 1) . The total incidence of animals with a renal tumor reached 25% (n ¼ 64) at the end of the study. At least 75% of these animals had unilateral renal carcinoma as determined by tumor size, proliferating and disorganized histopathology, and abundance of metastasis (Mantle et al., in press ).
Gene Selection and Clustering
Applying the stringency criteria for selection of significantly differentiated genes, statistical analysis revealed that the expression of 470 genes in the kidney and 233 genes in the liver were differentially modulated (p 0.001 in at least two time points) by the OTA treatment. Of these, only 45 genes were modulated in both kidney and liver.
Hierarchical clustering analysis was performed for kidney and liver mRNA expression profiles (Figs. 2A and 2B) . The vertical axis of the dendrograms represents each transcript, and the x-axis represents the various time points, and at the intersection of these two values, the expression intensity as compared to control (fold-expression) can be seen. The organization in both the horizontal and vertical axes represents the similarity of the expression values as detailed by the tree connecting each category. The distance of the connecting lines in the tree represents the extent of similarity. Gene expression clusters were generated accordingly; interestingly, the 7-day and 12-month profiles exhibited the most similar time points (in terms of the expression values of the affymetrix probes at these time points) in both organs. In the kidney, these two time points taken together are then most similar to the 7-month time point; these three are most similar to the 21-day and, finally, the 4-month time point. In the liver, these two time points taken as a cluster are most similar to the 12-month, 7-day, and finally, the 7-month time point. In both organs, down regulation was 122 the predominant effect, with 60% and 56% of genes downregulated in kidney and liver, respectively.
Further analysis of the gene expression profile in kidney and liver was performed by application of a single value decomposition (SVD) method along the time coordinate. The mean fold-expression values were plotted as a function of time (Figs. 2C and 2D) . In both organs, eight clusters with differentiated time-dependent expression profile were identified. The modulation of OTA-induced gene expression was generally less than two-fold. The two main clusters include only genes that, over the five time points, are either continuously up-regulated (31% in kidney, 25% in liver) or Grouping of genes modulated by OTA was performed according to their biological functions. For this analysis, a gene ontology approach was applied to genes exhibiting at least 1.5-fold expression values. The number of genes attributed to each functional class is depicted in Figure 3 , showing a wide diversity of highly tissue-selective biological responses. In the kidney, genes involved in xenobiotic metabolism and oxidative stress response were generally down-regulated by OTA, whereas this group of genes was much less modulated in the liver. Interestingly, many of these genes share the antioxidant regulatory element (ARE) as a regulatory motif (Table 1) . Other gene classes, such as several enzymes involved in fatty acid metabolism and cytochrome P450, were also selectively down-regulated in the kidney of OTA-treated animals. Many of these genes possess a common promoter targeted by the transcription factor hepatocyte nuclear factor alpha (HNF4a). Several genes, which belong to different functional classes and were down-regulated following OTA-treatment, were identified as being under transcriptional control of HNF4a (Table 2) . Of interest was the finding that the mRNA specific for HNF4a itself was down-regulated.
Expression of many transporter genes was down-regulated in the kidney (Table 3) . Several genes known as markers of kidney injury, cell regeneration, and oncogenesis were significantly modulated by OTA. For example, the kidney injury molecule (KIM-1, 4.4-fold) and the survival markers c-myc (3.7-fold), Akt-1 (1.7-fold), Polo-like kinase (Plk, 1.5-fold), and Cdkn1a alias p21 (2.3-fold) were up-regulated. The regucalcin (REG), also known as the senescence marker protein 30 (Smp30), was down-regulated more than 10-fold by OTA.
Only small changes occurred in expression of genes known to be involved in DNA synthesis and repair or in genes induced as a result of DNA damage. Few genes associated with DNA repair were slightly down-regulated. Similarly, very little or no effects were found on expression of apoptosis-related genes. Three genes involved in the regulation of protein synthesis were modulated by OTA. The prostaglandin F2 receptor negative regulator (Ptgfrn) and the eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1) were up-regulated 
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(3.2-and 1.5-fold, respectively), while the Elongation factor 1-alpha 1 (eEF1A-1) was down-regulated (ÿ3.3-fold).
Confirmation of Microarray Expression Data
In order to confirm the microarray data, selected gene products assigned to various functional classes were analyzed by quantitative real-time PCR (TaqMan-PCR). As with the microarray data, TaqMan RT-PCR data is presented as foldexpression value of OTA-treated samples as compared to controls. As shown in Figure 4 , expression values obtained with RT-PCR are highly comparable to the data generated by microarray technology.
Protein expression of six genes was measured from samples taken at the early and late time-points (21 days and 12 months) by Western blot analysis. A good correlation was observed between microarray data and measured protein expression (Fig. 5) .
DISCUSSION
OTA is a common trace contaminant of some foodstuffs. It produces various toxicological effects, the most relevant being nephrotoxicity and nephrocarcinogenicity in rat (NTP, 1989) . There is significant debate on the use of rat carcinogenicity data to assess the potential carcinogenic risk to humans. A very relevant question with respect to OTA-mediated carcinogenicity and risk assessment is whether the toxin acts through genotoxic or epigenetic mechanisms. For human safety assessment, a nongenotoxic mechanism of OTA would trigger the use of a health-based guidance value established by the application of uncertainty factors to the pivotal No Observed Adverse Effect Level obtained in animal studies (WHO, 2001 ).
The present work was aimed to generate data relevant to understanding the mechanism of OTA action and should help to select the most appropriate risk assessment procedure. This study was intended better to reflect the pattern of human exposure, and therefore, for the first time, oral feeding was chosen as the route of administration. This allowed ingestion of OTA in the most natural way for the experimental animals, homogenized into feed and consumed as desired, mainly in the dark part of the diurnal cycle. The dose was chosen to produce tumors, although avoiding overt nephrotoxicity, which could interfere with the carcinogenic process. A previous acute study had shown a marked difference between the toxicity of single (Miljkovic et al., 2003) . In the initial phase of the study (until rats reached 333 g), the chosen dose used (300 lg/kg bw) was twice that estimated as the highest average daily intake in the NTP study (NTP, 1989) , in which the toxin was administered by oral gavage. After rats reached 333 g, the dose was held to 100 lg/rat, aimed to gradually reduce the two-fold difference in intake between the NTP and the present regime as the body weight further increased. This protocol was considered to better mimic the human intake pattern (Mantle et al., in press ). Dosing adult rats according to body weight (as in the NTP study) would have resulted in an increasing exposure to OTA (due to weight gain from fat accumulation), which would not have reflected exposure of human adults. At a given occurrence level of OTA, human intake is likely to be relatively stable because of the limited expected age-dependent variations in body weight and food intake. The various selected time points represented early (7 and 21 days) and late (up to 12 months) exposure stages. The treatment was well tolerated, and cumulative incidence of animals with a renal tumor of 25% had occurred by the 2-year end point of the experiment. This incidence of carcinomas was significantly lower than that observed in the NTP study at the highest dose (Mantle et al., in press ). However, the development of renal cancer in this study makes it a suitable source for studying carcinogenic processes. The difference of cancer incidence between the two studies highlights the importance of the route of administration for tumor outcomes. OTA-modulated gene expression profiles were obtained in both kidney, the toxin's main target organ, and liver. Overall, the effects observed were relatively modest. Real-time PCR data confirmed the results. The effect on abundance of certain mRNAs correlated with the change in expression of respective proteins, suggesting that such OTA-induced changes could be of biological significance. The various clustering approaches showed the distinctive difference between kidney and liver responses, consistent with the known organ selectivity of OTA carcinogenicity in the male rat. It is also possible that the apparently higher susceptibility of kidney is due to a doseresponse effect from the elevated content and the prolonged residence of OTA in that organ. Indeed, it is well documented that OTA is actively transported in kidney cells O'Brien and Dietrich, 2005; WHO, 2001) . Hierarchical clustering analysis resulted in the identification of relatively complex and unexpected time-related responses. For example, a cluster was noted between the early response (at 7 days) and the late response (at 12 months). Currently, this finding is difficult to interpret. Time-related differences may occur as a result of toxicokinetics, treatment duration, and/or age-specific factors. The experimental design and the statistical approach applied in the present study did not allow thorough addressing of these factors.
General Markers of Nephrotoxicity and Carcinogenicity
Up-regulation of the prototypical renal toxicity marker kidney injury molecule (KIM-1) was observed in treated animals. KIM-1 is a type-1 membrane protein highly expressed both in early stage renal tubular injury and in regenerating proximal tubule epithelial cells (Ichimura et al., 1998) . Early induction of KIM-1 expression with a maximum at 21 days (21-fold) shows that the OTA-dose in the present study produced some nephrotoxicity, even if not clinically apparent. From a mechanistic perspective, this finding may be relevant. It is acknowledged that toxicity might induce tissue regeneration and cell proliferation, which may then promote tumor development. OTA-induced proliferation has been observed in vivo (NTP, 1989) and in vitro (Hong et al., 2000; Kamp et al., 2005) . However, there was no histological evidence of renal cell proliferation at any time point analyzed in this study, apart from the consistent presence of karyomegalic nuclei (data not shown). In the present study, genes implicated in cell survival and proliferation were induced by OTA, including cmyc (Amati et al., 1998) , Akt1 (Vanhaesebroeck and Alessi, 2000) , and Plk (Holtrich et al., 1994) . In addition, a strong upregulation of P-glycoprotein (P-gp) was observed. P-gp belongs to the ATP-binding cassette (ABC) multidrug transporter superfamily overexpressed in tumor cells (Thomas and Coley, 2003) .
Inhibition of protein synthesis is thought to be a major mode of OTA toxicity, although the exact molecular mechanism involved is not known (Creppy et al., 1983) . However, only few differentially expressed genes relate directly to a known mechanism of protein synthesis inhibition. The prostaglandin F2 receptor negative regulator (Ptgfrn; Orlicky, 1996) and the eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1; Gingras et al., 1999) were up-regulated. Both are documented to be involved in negative regulation of protein synthesis. In contrast, elongation factor 1-alpha 1 (eEF1A-1) was down-regulated. This protein is known to promote the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis (Petroulakis and Wang, 2002) . Although our data imply inhibition of protein synthesis, comprehensive data on protein expression and modification would be required for a more definite conclusion. For example, it is known that the activity of the Eif4ebp1 protein is dependent on its phosphorylation status (Gingras et al., 1999) .
One of the most striking effects obtained in the present study was a strong down-regulation of regucalcin, also known as the senescence marker protein30 (Smp30). The maximum effect was observed after 21 days of treatment. In kidney tubule cells, regucalcin is known to play a role in the regulation of intracellular Ca 2þ homeostasis. The reduction of regucalcin is compatible with documented effects of OTA on intracellular calcium and on calcium signaling homeostasis . In rat renal cortex, regucalcin was shown to produce a suppressive effect on DNA synthesis (Xue et al., 2000; Morooka and Yamaguchi, 2002) . Interestingly, recent studies have suggested that regucalcin may possess tumor suppression activity in hepatoma cells Yamaguchi, 2003, 2004) . Inhibition of regucalcin expression was also observed with other nephrotoxicant and nephrocarcinogenic compounds like cisplatin (Huang et al., 2001; Misawa and Yamaguchi, 2001) . Taken together, these data confirm a potential key role of calcium homeostasis in the mechanism of OTA action, which deserves further investigation.
OTA was found to significantly reduce the expression of a number of genes encoding transport proteins, such as those involved in organic anion transport. Similar trends were observed in an acute and high-dose experiment (Luhe et al., 2003) . Importantly, these results support previous physiological data in vitro and in vivo showing that chronic treatment with OTA resulted in an impairment of the secretion of organic anions in the proximal tubules (Gekle and Silbernagl, 1994; Gekle et al., 2005; Sauvant et al., 2005) . In this context it is interesting to note that angiotensinogen mRNA expression was down-regulated in our study. This may explain the effects of OTA on renal hemodynamics, which is thought to be mediated by angiotensin II .
The transport proteins Oat1, Oat-k1, and Oatp1 are well documented to selectively transport OTA (Gekle and Silbernagl, 1994; Gekle et al., 2005; O'Brien and Dietrich, 2005; Zepnik et al., 2003) . In our study they were markedly down-regulated at RNA and protein levels, indicating that OTA is likely to affect its own toxicokinetics. In addition, the down-regulation of transporters involved in the excretion of xenobiotic metabolites (e.g., multidrug resistance-associated protein 2, mrp2) may possibly result in interactions between OTA and other toxic chemicals.
Recently, it has been proposed that gene expression profiling can identify distinctive fingerprints or signatures to discriminate between compounds that act either as directly genotoxic or are genotoxic through indirect mechanisms (Dickinson et al., 2004; Hu et al., 2004) . Although this method of classification still requires validation, a trend has been observed in which direct-acting genotoxins induce toxicity-associated pathways followed by early modulation of specific genes related to DNAdamage. Interestingly, the genes reported as potentially specific for direct-acting genotoxins were not modulated in our study, which may strongly suggest an indirect genotoxic mechanism for OTA.
Disruption of Biological Pathways
Analysis of DNA-binding sites revealed that many genes down-regulated by OTA share the motif 5#-AGGTCA-3# as a DNA-binding domain. This sequence is the regulatory motif through which the transcription factor HNF4a acts (Ellrott et al., 2002) . This strongly suggests that OTA may disrupt HNF4a-dependent regulatory pathways. The exact mechanism involved in the inhibition of HNF4a-regulated gene expression is not clear, although it was found that down-regulation of HNF4a expression was observed at both mRNA and protein levels.
From the perspective of cancer development, the biological significance of down-regulation of HNF4a-regulated genes is difficult to define. Many of the HNF4a target genes play important roles in development, differentiation, and homeostasis FIG. 5 . Correlation between changes in gene and protein expression. Kidney protein lysates from control and OTA-treated animals were analyzed by Western blots and visualized by chemiluminescence. Transferred membranes were probed with antibodies specific to the following proteins: Gstp, Gclc, HNF4a, Oct2, Oat-k1, Oatp1 (cortex only), and Oatp1 (medulla only). Three controls and three samples from OTA-treated animals were analyzed at 21 days and 12 months. 130 (Sladek, 1993) , and the depletion of HNF4a-pathway was previously associated with cancer development (Sel et al., 1996) . HNF4a-expression and activity was analyzed in human renal carcinomas (Sel et al., 1996) . The data indicated that in tumor samples both the expression and activity of HNF4a were reduced as compared to normal tissue, suggesting that this pathway might be an important molecular mechanism in renal carcinogenesis. However, the present analyses occurred well before any renal tumors were evident in the OTA-treated rats.
In the kidney, OTA treatment resulted in an average 10-fold down-regulation of the expression of the male-specific, HNF4a-regulated cytochrome P450 CYP 2C11. CYP 2C11 is involved in phase I metabolism of endogenous compounds (i.e., steroids) and several xenobiotics (Riddick et al., 2004) . A potential role of CYP 2C11 in bioactivation of OTA was suggested (PfohlLeszkowicz et al., 1998) , but data indicating a strong downregulation of this gene do not support this hypothesis.
OTA has been reported to induce oxidative stress. For example, an increased formation of malondialdehyde (MDA) was observed in the kidney of rats exposed to 120 lg/kg bw/day of OTA for 60 days (Petrik et al., 2003) . Other studies confirmed lipid peroxidation as a result of OTA exposure (Omar et al., 1990; Sauvant et al., 2005) . Contrary to this, in another study, treatment of male rats with OTA (up to 2.0 mg/kg bw administered by oral gavage) did not increase the formation of biomarkers of oxidative damage such as the lipid peroxidation marker MDA in plasma, kidney, and liver, or the DNA damage marker 8-oxo-7,8-dihydro-2#deoxyguanosine in kidney DNA (Gautier et al., 2001b) . However, a significant increase in the expression of the marker of oxidative stress response HSP32 protein was observed in kidney but not in liver. Surprisingly, in the present study, many genes normally induced by oxidative stress were down-regulated during OTA treatment. This response was only observed in kidney, and the mechanism of this down-regulation is still unknown. Interestingly, these genes share the antioxidant regulatory element (ARE) as a regulatory motif in their promoter region. The ARE-motif is recognized by the nuclear factor-erythroid 2-related factor 2 (Nrf2), a member of the ''Cap-n-Collar'' family of basic-region leucine zipper transcription factors (Mathers et al., 2004) . Nrf2 is involved in both the basal expression and the induction of genes encoding mainly for detoxication, cytoprotective, and antioxidant enzymes (Lee and Johnson, 2004; Nguyen et al., 2004) . These proteins are responsible for cellular redox status and for cellular defense against oxidative damage. We are currently studying inhibition of Nrf2-activation by OTA as a molecular mechanism involved in OTA toxicity.
Although the expression of most of the renal Nrf2-regulated genes seemed to be inhibited by OTA treatment, a limited number of them appeared to be induced (e.g., Gsta2). It is important to note that, for many genes, the 5# promoter region may contain multiple binding sites specific for several transcription factors, and therefore the observed effects on mRNA expression may be the combined effects on different transcription factors. Previous investigations have provided evidence that phase II enzymes may not be regulated exclusively by Nrf2-mediated mechanisms (Kang et al., 2003) . For example, recent studies indicated that Nrf2 might not significantly contribute to the expression of Gsta1/2 in the mouse small intestine (McMahon et al., 2001) . Our results show that some Nrf2-regulated genes are not down-but up-regulated, suggesting that OTA may also alter other signaling pathways that have not yet been identified.
The toxicological consequences of the OTA-mediated downregulation of many Nrf2-regulated genes are likely to be biologically significant. It is well documented that chemicals inducing an oxidative stress response through activation of Nrf2 are associated with chemoprotective properties (Chen and Kong, 2004; Zhang and Gordon, 2004) . With OTA, the inhibition of expression of genes involved in the biosynthesis of glutathione (including the rate-limiting Gclc) is likely to result in a reduction of the cellular glutathione content, as already documented in OTA-treated cell cultures (Schaaf et al., 2002) . Because of its major importance in the cellular redoxbalance, a reduction of intracellular glutathione content should compromise the cellular defense against oxidative damage. 4-Hydoxynonenal (4-HNE) is a reactive metabolite resulting from lipid peroxidation that forms DNA adducts (Hartley et al., 1995) . Because of the affinity to conjugate 4-HNE with glutathione, Gstp is thought to play a role in the detoxication of this lipid peroxidation product (Hartley et al., 1995) . It can be hypothesized that the OTA-mediated down-regulation of Gstp may impair the detoxication of 4-HNE and thus result in increased oxidative damage.
Many Nrf2-regulated gene products down-regulated by OTA are involved in xenobiotic detoxication processes. They include several glutathione S-transferases and UDP-glucuronyltransferases. Their reduced expression may possibly result in a higher concentration of xenobiotics, normally detoxified by these enzymes, which could act synergistically with OTA, as suggested for OTA and other mycotoxins (Creppy et al., 2004) .
Finally, an attempt to link HNF4a and Nrf2-pathways pointed to protein kinase C (PKC) as a common regulatory feature. PKC is the major kinase involved in ARE-mediated gene induction by Nrf2 (Bloom and Jaiswal, 2003; Numazawa et al., 2003) and in activation of the HNF4aÿpathway (Hashimoto et al., 2005; Roy et al., 2001) . Notably, in our study several transport-related genes, reported to be regulated through PKC-dependent processes, were also down-regulated by OTA (see Table 2 ). These data strongly suggest that disruption of PKC-mediated processes may play a role in the toxicity of OTA (Fig. 6) . Further investigation is necessary to confirm this hypothesis.
Summary and Conclusion
In the present study significantly different gene expression profiles were observed in kidney and liver of male Fischer rats OCHRATOXIN A CARCINOGENICITY following chronic dietary exposure to OTA in a concentration sufficient to cause renal carcinoma late in life. Gene expression data indicated occurrence of renal toxicity, which may involve oxidative damage and eventually lead to cell proliferation and cancer. Gene expression analysis pointed toward predominant involvement of epigenetic mechanisms in OTA carcinogenicity. These mechanisms may include alteration of calcium homeostasis and disruption of pathways regulated by the transcription factors HNF4a and Nrf2. The depletion of Nrf2-regulated enzymes is likely to impair the cellular defense potential, resulting in chronic elevation of oxidative stress in the kidney. Sources of oxidants can be either endogenous (normal physiological processes) or exogenous (xenobiotics). Low concentration of antioxidants can result in cell proliferation and, ultimately, cancer development (Klaunig and Kamendulis, 2004) . Therefore, inhibition of cellular defense appears to be a highly plausible novel mechanism, which could contribute to OTA-mediated carcinogenicity. However, it has to be acknowledged that the present data do not provide any absolute demonstration of a direct link between the gene expression effects observed and the late development of tumors. Further investigations are necessary to further establish the relevance of the biological effects to the carcinogenic process. In addition, it has to be noted that the interpretation of gene expression data in this study has focused on significantly modulated genes. It is, of course, feasible that subtle changes in the expression of other genes, together with cell signaling and post-translational modification processes, which were not further analyzed in this study, are also implicated in OTA carcinogenesis and could help to accomplish the comprehension of the OTA mechanism of action. 
